HS 9401-71-10-10 – Chairs

Tariff data as of T2026-2, effective Sept 1, 2026, last verified Oct 21, 2026

US-origin goods: 50% surtax (United States Surtax Order (2026), SOR/2026-186, in force Sep 8, 2026)

Seats (other than those of heading 94.02), whether or not convertible into beds, and parts thereof. › Upholstered › Chairs

MFN duty rate

8 %

GST

5%

Unit of measure

-

Chairs

Estimate duty & taxes · Get classification help

Preferential tariff rates

• LDCT: Free
• Ukraine: Free
• CPTPP: Free
• Chile: Free
• Panama (PAT): Free
• Norway (NT): Free
• UST/CUSMA (US): Free
• UK: Free
• Peru: Free
• CETA: Free
• GPT: 5%
• CPTPP – United Kingdom (CPUKT): Free
• Korea: Free
• Iceland: Free
• Honduras (HNT): Free
• MXT/CUSMA (Mexico): Free
• Switzerland–Liechtenstein (SLT): Free
• Colombia: Free
• Jordan (JT): Free
• Israel (CIAT): Free
• Commonwealth Caribbean Countries Tariff (CCCT): Free
• Costa Rica (CRT): Free

Preference requires qualifying origin and origin proof or certification.

Frequently asked questions

What is the MFN duty on Chairs (HS 9401-71-10-10)?

The T2026-2 MFN rate for tariff item 9401.71.10 is 8%. Specific or compound rates require manual calculation. Classification and origin must be verified with CBSA.

What is the duty on HS 9401-71-10-10 from the US?

Qualifying US-origin goods with origin proof use UST/CUSMA at Free. US-origin goods: 50% surtax (United States Surtax Order (2026), SOR/2026-186, in force Sep 8, 2026) GST/HST and any applicable personal-import provincial tax are additional.

Which trade agreement rates apply to HS 9401-71-10-10?

LDCT: Free; Ukraine: Free; CPTPP: Free; Chile: Free; Panama (PAT): Free; Norway (NT): Free; UST/CUSMA (US): Free; UK: Free; Peru: Free; CETA: Free; GPT: 5%; CPTPP – United Kingdom (CPUKT): Free; Korea: Free; Iceland: Free; Honduras (HNT): Free; MXT/CUSMA (Mexico): Free; Switzerland–Liechtenstein (SLT): Free; Colombia: Free; Jordan (JT): Free; Israel (CIAT): Free; Commonwealth Caribbean Countries Tariff (CCCT): Free; Costa Rica (CRT): Free. Preferential treatment requires qualifying origin and certification. Rates are informational; CBSA is authoritative.